These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 12740497

  • 1. Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer.
    Chang CH, Wu HC, Tsai JJ, Shen YY, Changlai SP, Kao A.
    Urol Int; 2003; 70(4):311-5. PubMed ID: 12740497
    [Abstract] [Full Text] [Related]

  • 2. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D, Schlemmer HP, Wagner PH, Böttcher P, Merseburger AS, Aschoff P, Bares R, Pfannenberg C, Ganswindt U, Corvin S, Stenzl A.
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S.
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [Abstract] [Full Text] [Related]

  • 4. Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose.
    Heicappell R, Müller-Mattheis V, Reinhardt M, Vosberg H, Gerharz CD, Müller-Gärtner H, Ackermann R.
    Eur Urol; 1999 Dec; 36(6):582-7. PubMed ID: 10559612
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, Xu G, Yang W, Zhao S.
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [Abstract] [Full Text] [Related]

  • 6. 18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.
    Tilki D, Reich O, Graser A, Hacker M, Silchinger J, Becker AJ, Khoder W, Bartenstein P, Stief CG, Loidl W, Seitz M.
    Eur Urol; 2013 May; 63(5):792-6. PubMed ID: 22902037
    [Abstract] [Full Text] [Related]

  • 7. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
    Fricke E, Machtens S, Hofmann M, van den Hoff J, Bergh S, Brunkhorst T, Meyer GJ, Karstens JH, Knapp WH, Boerner AR.
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):607-11. PubMed ID: 12589476
    [Abstract] [Full Text] [Related]

  • 8. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY.
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [Abstract] [Full Text] [Related]

  • 9. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
    de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ.
    J Nucl Med; 2003 Mar; 44(3):331-5. PubMed ID: 12620996
    [Abstract] [Full Text] [Related]

  • 10. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
    Tanaka T, Terai Y, Yamamoto K, Yamada T, Ohmichi M.
    Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772
    [Abstract] [Full Text] [Related]

  • 11. Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
    Rouanne M, Girma A, Neuzillet Y, Vilain D, Radulescu C, Letang N, Yonneau L, Hervé JM, Botto H, Le Stanc E, Lebret T.
    Eur J Surg Oncol; 2014 Dec; 40(12):1724-30. PubMed ID: 25242381
    [Abstract] [Full Text] [Related]

  • 12. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
    Driscoll DO, Halpenny D, Johnston C, Sheehy N, Keogan M.
    Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
    [Abstract] [Full Text] [Related]

  • 13. [11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy.
    Schumacher MC, Radecka E, Hellström M, Jacobsson H, Sundin A.
    Scand J Urol; 2015 Feb; 49(1):35-42. PubMed ID: 25001948
    [Abstract] [Full Text] [Related]

  • 14. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
    Ottenhof SR, Djajadiningrat RS, Versleijen MWJ, Donswijk ML, van der Noort V, Brouwer OR, Graafland NM, Vegt E, Horenblas S.
    Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
    [Abstract] [Full Text] [Related]

  • 15. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer.
    Sun SS, Chen TC, Yen RF, Shen YY, Changlai SP, Kao A.
    Anticancer Res; 2001 Jan; 21(4B):2957-61. PubMed ID: 11712793
    [Abstract] [Full Text] [Related]

  • 16. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
    Zhang X, Wu F, Han P.
    Hell J Nucl Med; 2014 Jan; 17(3):177-83. PubMed ID: 25526754
    [Abstract] [Full Text] [Related]

  • 17. Pelvic Lymph Node Staging by Combined 18F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy.
    Pichler R, De Zordo T, Fritz J, Kroiss A, Aigner F, Heidegger I, Virgolini I, Horninger W, Uprimny C.
    Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364
    [Abstract] [Full Text] [Related]

  • 18. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH, Bouchelouche K, Høilund-Carlsen PF, Petersen H, Gerke O, Steffansen SI, Marcussen N, Svolgaard N, Vach W, Geertsen U, Walter S.
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [Abstract] [Full Text] [Related]

  • 19. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
    Tsai CS, Chang TC, Lai CH, Tsai CC, Ng KK, Hsueh S, Yen TC, Hong JH.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1506-12. PubMed ID: 15050330
    [Abstract] [Full Text] [Related]

  • 20. Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings.
    Inubashiri E, Hata K, Kanenishi K, Shiota A, Ohno M, Yamamoto Y, Nishiyama Y, Ohkawa M, Hata T.
    J Obstet Gynaecol Res; 2009 Feb 01; 35(1):26-34. PubMed ID: 19215544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.